Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double‐Blind, Active‐Controlled Multicenter Study

Background A new botulinum toxin type A (NBoNT) produced from the same strain of Clostridium botulinum as onabotulinumtoxinA (OBoNT) is widely used in Asia. Objectives To compare the efficacy and safety of NBoNT and OBoNT for moderate to severe glabellar wrinkles. Methods A double‐blind, randomized,...

Ausführliche Beschreibung